REIT - Healthcare Facilities
Compare Stocks
3 / 10Stock Comparison
GMRE vs CHCT vs NXRT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Residential
GMRE vs CHCT vs NXRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities | REIT - Residential |
| Market Cap | $94M | $504M | $748M |
| Revenue (TTM) | $148M | $122M | $252M |
| Net Income (TTM) | $2M | $6M | $-32M |
| Gross Margin | 68.8% | 62.7% | 91.1% |
| Operating Margin | 24.9% | 39.8% | 11.5% |
| Forward P/E | 595.7x | 37.5x | — |
| Total Debt | $654M | $536M | $1.56B |
| Cash & Equiv. | $7M | $3M | $14M |
GMRE vs CHCT vs NXRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Global Medical REIT… (GMRE) | 100 | 66.7 | -33.3% |
| Community Healthcar… (CHCT) | 100 | 46.9 | -53.1% |
| NexPoint Residentia… (NXRT) | 100 | 88.1 | -11.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GMRE vs CHCT vs NXRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs NXRT's 216.0%
- Lower volatility, beta 0.48, current ratio 0.03x
CHCT carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 4.7%, EPS growth 133.7%, 3Y rev CAGR 7.5%
- 4.7% FFO/revenue growth vs NXRT's -3.2%
- Better valuation composite
NXRT plays a supporting role in this comparison — it may shine differently against other peers.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.7% FFO/revenue growth vs NXRT's -3.2% | |
| Value | Better valuation composite | |
| Quality / Margins | 5.0% margin vs NXRT's -12.7% | |
| Stability / Safety | Beta 0.48 vs NXRT's 0.62, lower leverage | |
| Dividends | 63.5% yield, 5-year raise streak, vs NXRT's 7.2% | |
| Momentum (1Y) | +14.4% vs NXRT's -17.3% | |
| Efficiency (ROA) | 0.6% ROA vs NXRT's -1.7%, ROIC 1.6% vs 1.1% |
GMRE vs CHCT vs NXRT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
GMRE vs CHCT vs NXRT — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CHCT leads in 2 of 6 categories
GMRE leads 2 • NXRT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CHCT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NXRT is the larger business by revenue, generating $252M annually — 2.1x CHCT's $122M. CHCT is the more profitable business, keeping 5.0% of every revenue dollar as net income compared to NXRT's -12.7%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $148M | $122M | $252M |
| EBITDAEarnings before interest/tax | $95M | $92M | $125M |
| Net IncomeAfter-tax profit | $2M | $6M | -$32M |
| Free Cash FlowCash after capex | $19M | $60M | $79M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +62.7% | +91.1% |
| Operating MarginEBIT ÷ Revenue | +24.9% | +39.8% | +11.5% |
| Net MarginNet income ÷ Revenue | +1.7% | +5.0% | -12.7% |
| FCF MarginFCF ÷ Revenue | +12.6% | +49.5% | +31.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.7% | +4.0% | +0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -166.2% | +124.4% | 0.0% |
Valuation Metrics
GMRE leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 115.3x trailing earnings, GMRE trades at a 49% valuation discount to CHCT's 227.9x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than NXRT's 18.5x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $94M | $504M | $748M |
| Enterprise ValueMkt cap + debt − cash | $741M | $1.0B | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | 115.29x | 227.91x | -23.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 595.67x | 37.53x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.35x | 16.25x | 18.53x |
| Price / SalesMarket cap ÷ Revenue | 0.68x | 4.16x | 2.98x |
| Price / BookPrice ÷ Book value/share | 0.17x | 1.10x | 2.49x |
| Price / FCFMarket cap ÷ FCF | — | 8.93x | 8.95x |
Profitability & Efficiency
CHCT leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CHCT delivers a 1.4% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-10 for NXRT. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), CHCT scores 6/9 vs NXRT's 4/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +0.5% | +1.4% | -10.1% |
| ROA (TTM)Return on assets | +0.2% | +0.6% | -1.7% |
| ROICReturn on invested capital | +2.0% | +1.6% | +1.1% |
| ROCEReturn on capital employed | +5.3% | +2.3% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 4 |
| Debt / EquityFinancial leverage | 1.18x | 1.25x | 5.18x |
| Net DebtTotal debt minus cash | $647M | $533M | $1.5B |
| Cash & Equiv.Liquid assets | $7M | $3M | $14M |
| Total DebtShort + long-term debt | $654M | $536M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | 1.14x | 1.15x | 0.47x |
Total Returns (Dividends Reinvested)
GMRE leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GMRE five years ago would be worth $8,026 today (with dividends reinvested), compared to $5,559 for CHCT. Over the past 12 months, CHCT leads with a +14.4% total return vs NXRT's -17.3%. The 3-year compound annual growth rate (CAGR) favors GMRE at 1.5% vs CHCT's -14.0% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +6.9% | +10.9% | +1.5% |
| 1-Year ReturnPast 12 months | -0.7% | +14.4% | -17.3% |
| 3-Year ReturnCumulative with dividends | +4.7% | -36.4% | -17.1% |
| 5-Year ReturnCumulative with dividends | -19.7% | -44.4% | -20.9% |
| 10-Year ReturnCumulative with dividends | +308.1% | +81.6% | +216.0% |
| CAGR (3Y)Annualised 3-year return | +1.5% | -14.0% | -6.1% |
Risk & Volatility
Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.
Risk & Volatility
GMRE is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than NXRT's 0.62 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHCT currently trades 96.8% from its 52-week high vs NXRT's 76.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 0.60x | 0.62x |
| 52-Week HighHighest price in past year | $39.93 | $18.22 | $38.64 |
| 52-Week LowLowest price in past year | $29.05 | $13.23 | $23.79 |
| % of 52W HighCurrent price vs 52-week peak | +89.5% | +96.8% | +76.3% |
| RSI (14)Momentum oscillator 0–100 | 52.7 | 52.3 | 67.6 |
| Avg Volume (50D)Average daily shares traded | 104K | 234K | 222K |
Analyst Outlook
Evenly matched — GMRE and NXRT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GMRE as "Buy", CHCT as "Hold", NXRT as "Hold". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -8.4% for NXRT (target: $27). For income investors, GMRE offers the higher dividend yield at 63.51% vs NXRT's 7.15%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | $40.00 | $18.50 | $27.00 |
| # AnalystsCovering analysts | 22 | 16 | 10 |
| Dividend YieldAnnual dividend ÷ price | +63.5% | +11.3% | +7.2% |
| Dividend StreakConsecutive years of raises | 5 | 11 | 12 |
| Dividend / ShareAnnual DPS | $22.70 | $2.00 | $2.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.4% | +1.0% |
CHCT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 2 (Valuation Metrics, Total Returns). 2 tied.
GMRE vs CHCT vs NXRT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GMRE or CHCT or NXRT a better buy right now?
For growth investors, Community Healthcare Trust Incorporated (CHCT) is the stronger pick with 4.
7% revenue growth year-over-year, versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GMRE or CHCT or NXRT?
On trailing P/E, Global Medical REIT Inc.
(GMRE) is the cheapest at 115. 3x versus Community Healthcare Trust Incorporated at 227. 9x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — GMRE or CHCT or NXRT?
Over the past 5 years, Global Medical REIT Inc.
(GMRE) delivered a total return of -19. 7%, compared to -44. 4% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus CHCT's +81. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GMRE or CHCT or NXRT?
By beta (market sensitivity over 5 years), Global Medical REIT Inc.
(GMRE) is the lower-risk stock at 0. 48β versus NexPoint Residential Trust, Inc. 's 0. 62β — meaning NXRT is approximately 30% more volatile than GMRE relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — GMRE or CHCT or NXRT?
By revenue growth (latest reported year), Community Healthcare Trust Incorporated (CHCT) is pulling ahead at 4.
7% versus -3. 2% for NexPoint Residential Trust, Inc. (NXRT). On earnings-per-share growth, the picture is similar: Community Healthcare Trust Incorporated grew EPS 133. 7% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, CHCT leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GMRE or CHCT or NXRT?
Global Medical REIT Inc.
(GMRE) is the more profitable company, earning 4. 8% net margin versus -12. 7% for NexPoint Residential Trust, Inc. — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus 11. 1% for NXRT. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GMRE or CHCT or NXRT more undervalued right now?
On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.
5x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — GMRE or CHCT or NXRT?
All stocks in this comparison pay dividends.
Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 7. 2% for NexPoint Residential Trust, Inc. (NXRT).
09Is GMRE or CHCT or NXRT better for a retirement portfolio?
For long-horizon retirement investors, Global Medical REIT Inc.
(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, CHCT: +81. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GMRE and CHCT and NXRT?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.